Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Neurological Disorders and Stroke (NINDS), along with other Institutes and Centers at the NIH, aims to support clinical trials and ancillary studies conducted within established NIH-funded Clinical Trial Research Networks. This initiative focuses on multi-center clinical trials that utilize existing network infrastructure and involves cooperative oversight by the administering Institute or Center. The funding mechanism follows a bi-phasic, milestone-driven cooperative agreement model (UG3/UH3), starting with an initial planning and start-up phase lasting up to two years, with potential progression to an implementation phase lasting up to five additional years. Currently, applications are not being solicited; this notice serves to give potential applicants ample time to establish collaborations and prepare responsive proposals. Interested parties are encouraged to contact the NINDS Division of Clinical Research for further details. The program’s objective is to facilitate scientifically rigorous clinical trials within established networks, fostering collaborative research efforts across multiple centers under the NIH funding umbrella.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Neurological Disorders and Stroke (NINDS), in conjunction with additional Institutes/Centers (ICs)at the National Institutes of Health seek to support projects proposing Clinical Trials and Ancillary Studies that are conducted within NIH-Funded Clinical Trial Research Networks.
The program will encourage applications for multi-center clinical trials to be conducted within an established Clinical Trial Research Network funded by one of multiple NIH Institutes and Centers. Following peer review, the IC will prioritize studies to be conducted within the established network infrastructure with cooperative oversight by the administering IC. The program will use the bi-phasic, milestone driven UG3/UH3 cooperative agreement activity code. Awards will initially support an up to 2- year milestone-driven planning and start-up phase, with possible transition to an implementation (UH3) phase of up to 5 additional years.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. For additional information, potential applicants are encouraged to contact program staff listed below.
